MLH1 and ovarian neoplasm: Interestingly, Watanabe and coworkers [9] described induction of MSI in ovarian tumours from patients studied before and after they received cisplatin-based chemotherapy, but in their study the cisplatin-induced MSI correlated with a significant decrease in hMLH1 expression.